SCHEMBL5717022

SCHEMBL5717022

O=C(O)[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.66
HTT P42858 1/20 0.66
BRD4 O60885 3/20 0.60
HSD11B1 P28845 1/20 0.54
BRD2 P25440 2/20 0.54
HCRTR1 O43613 2/20 0.53
HCRTR2 O43614 2/20 0.53
KDM4E B2RXH2 1/20 0.51
HSD17B10 Q99714 1/20 0.51
EPHX2 P34913 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
KCNQ1 P51787 1/20 0.51
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
BRD3 Q15059 1/20 0.48
BRDT Q58F21 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5716989 1.00 ALDH1A1 (0.66) ALDH1A1HTTBRD4HSD11B1BRD2
SCHEMBL5716988 1.00 ALDH1A1 (0.66) ALDH1A1HTTBRD4HSD11B1BRD2
SCHEMBL2705744 0.96 BRD4 (0.65) ALDH1A1HTTBRD4BRD2HCRTR1
SCHEMBL2705750 0.96 BRD4 (0.65) ALDH1A1HTTBRD4BRD2HCRTR1
SCHEMBL5717368 0.88 BRD4 (0.56) ALDH1A1HTTBRD4HSD11B1BRD2
SCHEMBL23787095 0.87 BRD4 (0.80) ALDH1A1BRD4BRD2HCRTR1HCRTR2
SCHEMBL20291400 0.87 BRD4 (0.80) ALDH1A1BRD4BRD2HCRTR1HCRTR2
SCHEMBL32691722 0.86 ALDH1A1 (0.70) ALDH1A1HTTHSD11B1MEN1KMT2A
SCHEMBL6962263 0.86 ALDH1A1 (0.72) ALDH1A1HTTTDP1L3MBTL1
SCHEMBL15648472 0.86 ALDH1A1 (0.72) ALDH1A1HTTTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664010-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS Vernalis (R&D) Limited (GB) 2006-06-07 EP disclosed
WO-2005068448-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2005-07-28 WO disclosed